Mapping of the domains required for decay acceleration activity of the human factor H‐like protein 1 and factor H
- 1 October 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (10) , 2383-2387
- https://doi.org/10.1002/eji.1830261017
Abstract
The human factor H‐like protein 1 (FHL‐1) is composed of seven repetitive elements (short consensus repeats; SCR) that are identical in sequence to the seven N‐terminal SCR of complement factor H. We show that the FHL‐1 protein has decay acceleration activity in that it can dissociate C3/C5‐convertases bound to the surface of sheep red blood cells. The same activity was also determined for factor H. However, compared to FHL‐1, factor H was more efficient in decay acceleration, as about 100‐fold less protein was required for a 50% inhibition of activity. The domain required for decay accelerating activity of FHL‐1 and factor H was mapped by the use of recombinant fragments. FHL‐1 and a series of truncated forms of the protein were expressed in the baculovirus system. Recombinant FHL‐1 and all mutants which include SCR 1–4 were functionally active. These four N‐terminal SCR are essential and sufficient for activity, as deletion mutants which lack SCR 1 or SCR 4 showed no activity. These results demonstrate that FHL‐1 and factor H have identical and overlapping regulatory functions in the complement system and that the domain required for this activity is located in the overlapping region of both proteins within the N‐terminal four SCR.Keywords
This publication has 21 references indexed in Scilit:
- The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteinsGene, 1995
- Complement factor H and related proteins: an expanding family of complement-regulatory proteins?Immunology Today, 1994
- Regulation of Alternative Pathway Complement Activation by Glycosaminoglycans: Specificity of the Polyanion Binding Site on Factor HBiochemical and Biophysical Research Communications, 1994
- Human complement factor H: An additional gene product of 43kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complementEuropean Journal of Immunology, 1989
- Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38‐kDa tryptic fragment containing the binding site for C3bEuropean Journal of Immunology, 1986
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.The Journal of Experimental Medicine, 1979
- Interaction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding.The Journal of Experimental Medicine, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Modulation of C3b Hemolytic Activity by a Plasma Protein Distinct from C3b InactivatorScience, 1976